Iran International’s audience, by sending messages, said that the prices of nervous system and mental health medicines—especially scarce medicines—have increased significantly and that some foreign samples for treating depression and anxiety have become unavailable.

Babak Khati, a doctor and pediatric specialist, said that drug market monopoly, graft in imports and distribution, and the absence of effective oversight are the main factors behind medicine shortages in Iran.